You are here

chemotherapy

Naturally-Derived Cancer Drugs Provide Clues As To How Microbiome May Cause Chemotherapy Resistance

Naturally-Derived Cancer Drugs Provide Clues As To How Microbiome May Cause Chemotherapy Resistance

Forbes

Flag link:

Many Breast Cancer Patients Can Safely Skip Chemo, Large Trial Confirms

Many Breast Cancer Patients Can Safely Skip Chemo, Large Trial Confirms

Forbes

early-stage breast cancer

Genomics Health

Flag link:

ASCO18: Tecentriq scores again in lung cancer, but Keytruda looms in background

ASCO18: Tecentriq scores again in lung cancer, but Keytruda looms in background

Biopharma Dive

advanced squamous non-small cell lung cancer

Flag link:

Heart group warns of cardiovascular risks after treatment for breast cancer

Heart group warns of cardiovascular risks after treatment for breast cancer

Stat

Flag link:

Tesaro wins FDA OK for an IV version of chemo drug, launches discovery deal with Evotec

Tesaro wins FDA OK for an IV version of chemo drug, launches discovery deal with Evotec

Endpoints

Flag link:

Novartis bags FDA OK for Rydapt, adding a new chemo combo drug for AML

Novartis bags FDA OK for Rydapt, adding a new chemo combo drug for AML

Endpoints

acute myeloid leukemia

Flag link:

Kite Pharma’s CAR-T Clinical Trial To Use Chemotherapy Drug Implicated In Patient Deaths

Kite Pharma’s CAR-T Clinical Trial To Use Chemotherapy Drug Implicated In Patient Deaths

Xtalks

clinical trials

Juno Therapeutics

Flag link:

Beyond Chemotherapy: 4 Unique Ways Drug Developers Are Fighting Back Against Cancer

Beyond Chemotherapy: 4 Unique Ways Drug Developers Are Fighting Back Against Cancer

Motley Fool

cancer immunotherapies

Bristol-Myers Squibb

targeted therapies

Threshold Pharmaceuticals

Flag link:

FDA approves J&J's chemotherapy Yondelis

FDA approves J&J's chemotherapy Yondelis

Yahoo/Reuters

soft tissue sarcomas

Flag link:

Patients With Advanced Breast, Lung, Esophageal, and Colorectal Cancers Respond to Immunomedics' Novel Antibody-Directed Chemotherapy After Failing Multiple Prior Standard Treatments

Patients With Advanced Breast, Lung, Esophageal, and Colorectal Cancers Respond to Immunomedics' Novel Antibody-Directed Chemotherapy After Failing Multiple Prior Standard Treatments

Yahoo

esophageal cancer

colorectal cancer

sacituzumab govitecan

Flag link:

OncoGenex Has A Potential Blockbuster Drug, But The Markets Are Pricing It Like An Orphan

OncoGenex Has A Potential Blockbuster Drug, But The Markets Are Pricing It Like An Orphan

Seeking Alpha

Isis Pharmaceuticals

Teva Pharmaceuticals

Flag link:

Aldoxorubicin Continues To Prove Itself As A Viable Cancer Treatment

Aldoxorubicin Continues To Prove Itself As A Viable Cancer Treatment

Seeking Alpha

Flag link:

Rexahn's Recent Clinical Data Points To A New And Better Chemotherapy Pill

Rexahn's Recent Clinical Data Points To A New And Better Chemotherapy Pill

Seeking Alpha

Bristol-Myers Squibb

Flag link:

J&J releases more Doxil to the market

J&J releases more Doxil to the market

Fierce Pharma

Flag link:

Almost one-third of chemotherapy used "off-label"

Almost one-third of chemotherapy used "off-label"

Reuters

Flag link:

New Drug Could Enhance the Accuracy of Chemotherapy

New Drug Could Enhance the Accuracy of Chemotherapy

Yahoo

Flag link:

Isis Means Business With This New Treatment

Isis Means Business With This New Treatment

Wall St. Cheat Sheet

Isis Pharmaceuticals

advanced cancer

Flag link:

Merrimack IPO: Repackaging And Refining Chemotherapy

Merrimack IPO: Repackaging And Refining Chemotherapy

Seeking Alpha

Merrimack Pharmaceuticals

Flag link:

Apricus Biosciences acquires cancer drug

Apricus Biosciences acquires cancer drug

SignOnSanDiego.com, CA

Apricus Biosciences

Flag link:

Delcath's ChemoSat goes another round with the FDA

Delcath's ChemoSat goes another round with the FDA

Flag link:

Pages